New investor Credit Suisse Asset Management led the round and all existing preferred equity investors participated. All proceeds will help the company’s sales and marketing infrastructure grow.
Lanx’s device portfolio focuses on minimally invasive spine fusion solutions throughout the U.S., Mexico and Europe.
More Articles on Devices:
A Model for Clinical, Financial Success in Orthopedics
MAKO Surgical Reports 26% Q1 Revenue Increase, MAKOplasty Surgeries Up 30%
Globus Medical Launches New Spinal Surgery System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
